<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>At least 60 case studies of <z:hpo ids='HP_0001909'>leukemia</z:hpo> among people exposed to <z:hpo ids='HP_0011010'>chronic</z:hpo> low-dose <z:chebi fb="7" ids="30216">alpha-particle</z:chebi> radiation from injections with the radiographic contrast medium Thorotrast and 115 cases from follow-up studies have been described in the literature </plain></SENT>
<SENT sid="1" pm="."><plain>In the present study, malignant <z:e sem="disease" ids="C0018939" disease_type="Disease or Syndrome" abbrv="">hematological diseases</z:e> among 1003 Danish patients injected during 1935-1947 and followed to 1992 accruing 20,433 person-years were assessed and available histopathological specimens revised </plain></SENT>
<SENT sid="2" pm="."><plain>The mean cumulative bone marrow <z:chebi fb="7" ids="30216">alpha-particle</z:chebi> radiation dose (1.34 Gy) was estimated from records of the amount of Thorotrast injected (mean 18.7 ml) </plain></SENT>
<SENT sid="3" pm="."><plain>Sixteen cases of <z:hpo ids='HP_0004808'>acute myelogenous leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) and seven cases of <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) were diagnosed 8-40 years after injection, the cumulative frequency reaching 7.6% </plain></SENT>
<SENT sid="4" pm="."><plain>No significant relationship was seen between the cumulative frequency of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> + <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and the age at injection, gender, or amount of Thorotrast injected, but a multivariate analysis described data best by a model with the bone marrow dose and the power of the attained age </plain></SENT>
<SENT sid="5" pm="."><plain>The risk estimate for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> + <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> was 173 cases/10(4) persons per Gy </plain></SENT>
<SENT sid="6" pm="."><plain>If also considering cases of <z:hpo ids='HP_0011009'>acute</z:hpo> lymphocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> (1), <z:hpo ids='HP_0005506'>chronic myelogenous leukemia</z:hpo> (3), non-Hodgkins <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (4), and <z:hpo ids='HP_0006775'>multiple myeloma</z:hpo> (2), the risk estimate became 248 cases/10(4) persons per Gy </plain></SENT>
<SENT sid="7" pm="."><plain>It is suggested that RBE of <z:chebi fb="7" ids="30216">alpha particles</z:chebi> from <z:chebi fb="8" ids="33385">thorium</z:chebi> may be lower than 20 </plain></SENT>
</text></document>